Establishment of Human Mesothelioma Cell Lines (MS-1, -2) and Production of a Monoclonal Antibody (Anti-MS) with Diagnostic and Therapeutic Potential

Cancer Research

Volumn 48, Issue 18, 1988, Pages 5228-5236

  Hsu, Su Ming ^a   Hsu, Pei Line ^a   Zhao, Xun ^a   Kao Shan, Chien Song ^b   Whang Peng, Jacqueline ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; MONOCLONAL ANTIBODY; VIMENTIN;

CELL CULTURE; CYTOLOGY; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; TUMOR CELL LINE; ULTRASTRUCTURE;

ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY COMPLEX; CELL LINE; CHROMOSOME BANDING; HUMAN; IMMUNOHISTOCHEMISTRY; KERATIN; MESOTHELIOMA; MICROSCOPY, ELECTRON; MICROSCOPY, ELECTRON, SCANNING; PLEURAL NEOPLASMS; VIMENTIN;

EID: 0023742563     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Browne, K. Mesothelioma registry data. Lancet. ii(8499):167, 1986.
2. Battifora, H., and Kopinski, M. I. Distinction of mesothelioma from adeno carcinoma. An immunohistochemical approach. Cancer (Phila.), 55:1679-1685, 1985.
3. Corson, J. M., and Pinkus, G. S. Mesothelioma: Profile of keratin proteins and carcinoembryonic antigen. An immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am. J. Pathol., 108:80-87, 1982.
4. Churg, A. Immunohistochemical staining for vimentin and keratin in malignant mesothelioma. Am. J. Surg. Pathol., 9:360-365, 1985.
5. Epstein, A. L., Variakojis, D., Berger, C., and Hecht, B. K. Use of novel chemical supplements in the establishment of three malignant lymphoma cell lines. Int. J. Cancer, 35:619-627, 1985.
6. Hsu, S. M., Raine, L., and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29:577-580, 1981
7. Hsu, S. M., and Soban, E. Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohisto chemistry. J. Histochem. Cytochem., 30:1079-1082, 1982.
8. Hsu, S. M., Raine, L., and Fanger, H. A comparative study of the peroxidase antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. Clin. Pathol., 75:734-738, 1981.
9. Hsu, S. M., and Hsu, P. L. Phenotypes and phorbol ester-induced differentiation of human histiocytic lymphoma cell lines (U-937 and SU-DHL-)1 and Reed-Sternberg cells. Am. J. Pathol., 122:223-230, 1986.
10. Ho, Y. S., Chakraborty, S., and Hsu, S. M. Induction of differentiation of Burkitt's lymphoma cell lines by phorbol ester: Possible relationship with pre-B cells or immature B cells. Cancer Invest., 5:101-107, 1987.
11. Hsu, S. M., Zhao, X., Hsu, P. L., and Lok, M. S. Extracellular matrix does not induce the proliferation, but promotes the differentiation of Hodgkin's cell line HDLM-1. Am. J. Pathol., 127:9-14, 1987.
12. Seabright, M. A rapid banding technique for human chromosomes. Lancet, 2:971-972, 1971.
13. Harden, D. G., and Klinger, H. P. (eds.) ISCN: An international system for human cytogenetic nomenclature. Basel: S. Karger. Published in collaboration with Cytogenet. Cell Genet, pp. 1-118, 1985.
14. Caspersson, T., Zech, L., and Johansson, C. Differential binding of alkylating fluorochromes in human chromosomes. Exp. Cell Res., 60:315-319, 1970.
15. Hsu, S. M., Pescovitz, M. D., and Hsu. P. L. Monoclonal antibodies against SU-DHL-I cell stain the neoplastic cells of true histiocytic lymphoma, malignant histiocytosis and Hodgkin's disease. Blood, 68:213-219, 1986.
16. Hsu, S. M., Pescovitz, M., and Hsu, P. L. Monoclonal antibodies for histiocyte/interdigitating reticulum cell-related lymphomas. In: R. A. Reis feld and S. Sell (eds.): Monoclonal Antibodies and Cancer Therapy. UCLA symposium on molecular and cellular biology. Vol. 27. pp. 53-62. New York: Alan R. Liss, 1985.
17. Hsu, S. M., Hsu, P. L., Mulshine, J. Ho, Y. S., Ge, Z. H., And Huang, L. Ultrastructural and biochemical studies of Leu Ml antigens in granulocytes and H-RS cells in Hodgkin's disease. J. Natl. Cancer Inst., 77:363-370, 1986.
18. Ritz, J., Pesando, J. M., Notis-McConarty, J., and Schlossman, S. F. Modulation of human acute lymphoblastic leukemia antigen induced by monoclonal antibody in vitro. J. luminimi., 125:1506-1514, 1980.
19. Pesando, J. M., Ritz, J., Lazarus, H., Tomaselli, K. J., and Schlossman, S. F. Fate of a common acute lymphoblastic leukemia antigen during modulation by monoclonal antibody. J. Immunol., 726:540-544, 1981.
20. Hsu, S. M., Ho, V. S., and Hsu, P. L. The effect of monoclonal antibodies on the surface antigens of Reed-Sternberg cells. J. Natl. Cancer Insl., 79:1091-1099, 1987.
21. Sheibani, K., Battifora, H., Burke, J. S., and Rappaport, H. Leu-Mi antigen in human neoplasms: An immunohistologic study of 400 cases. Am. J. Surg. Pathol., 10:227-236, 1986.
22. Szpak, C. A., Johnston, W. W., Roggi, V., Kolbeck, J., Lottich, S. C., Vollmer, R., Thor, A., and Schlom, J. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3). Am. J. Pathol., 122: 252-260, 1986.
23. Behbehani, A. M. Studies of a human mesothelioma. Hum. Pathol., 13:862-866, 1982.
24. Reale, F. R., Griffin, T. W., Compton, J. M., Graham, S., Townes, P. L., and Bogden, A. Characterization of a human malignant mesothelioma cell line (H-MESO-1): A biphasic solid and ascites tumor model. Cancer Res., 47:3199-3205, 1987.
25. Carney, D. N., Gaidar, A. F., Bepler, G., Guccion, J. G., Marangos. P. J., Moddy, T. W., Zweig, M. H., and Minna, J. D. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res., 45:2913-2923, 1985.
26. Holland, J. F. Establishment and characterization of a human mesothelioma. Proc. Am. Assoc. Cancer Res., 20:62, 1979.
27. Tibbetts, L. M. Loss and restoration of tumorigenicity in a human mesothelioma cell line. Proc. Am. Assoc. Cancer Res., 25:45, 1984.
28. Anderson, T. M., Shin, W. Y., Benedict, W. F., Holmes, E. C., and Saxton, R. E. Establishment of a human fibrous mesothelioma cell line. Proc. Am. Assoc. Cancer Res., 28:31, 1987.
29. Anderson, T. M., Holmes, E. C., Kosaka, C. J., Cheng, L., and Saxton, R. E. Monoclonal antibodies to human malignant mesothelioma. J. Clin. Immunol., 7:254-261, 1987.
30. Ramaekers, F. C. S., Puts, J. G., Kant. A., Moesker, O., Jap, P. H. K., and Vooijs, G. P. Coexpression of keratin-and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc. Natl. Acad. Sci. USA, 80:2618-2622, 1983.
31. LaRocca, P. J., and Rheinwald, J. G. Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture. Cancer Res., 44:2991-2999, 1984.
32. Bunn, P. A., Jr., Carrasquillo, J. A., Keean, A. M., Reynolds, J. C., Schroff, R. W., Foon, K. A., Hsu, S. M., Gazdar, A. F., Mulshine, J. M., Old, R. K., Perentesis, P., Horowitz, M., Eddy, J., James, P., and Larson, S. M. Imaging of T cell lymphoma by radiolabeled monoclonal antibody. Lancet, 2:1219-1221, 1984.